The risks of using compounding pharmacies for GLP-1 medications
GLP-1 medications like Ozempic and Monjaro have gained popularity for weight loss, leading to rising costs for insurance companies. Studies show that GLP-1s can lead to substantial weight loss, with some individuals losing up to 10% of their body weight when used appropriately. And from 2022 and 2023, prescriptions of GLP-1 medications for obesity patients more than
Continue Reading